PIUG 2013 Annual Conference - An International Conference for Patent Information Professionals
Celebrating our Past 25 Years... Preparing for Our Future: Best Practices for Keeping Up with the Rapidly Changing Patent Landscape
Saturday, April 27 – Thursday May 2, 2013 Hilton Alexandria Mark Center 5000 Seminary Road Alexandria, VA +1-703-845-1010
Overview The conference will feature world-renowned experts on patent information for technology research and planning, for legal organizations, and for overall corporate IP management (technology licensing and related activities). The conference will include many opportunities for discussion and part of Tuesday afternoon will be dedicated to visiting the exhibit hall. Many workshops will also be held in conjunction with this meeting (before, during and after the technical sessions).
Attendees typically have a professional, scientific, or technical interest in patents and represent a multitude of companies. Previous meetings in Cincinnati, Ohio, and Denver, Colorado, drew enthusiastic groups of over 350 and 380 people, respectively, to the three-day technical sessions. Nearly one-fifth of the attendees were international; that is, attendees came from Australia, Austria, Brazil, Canada, China, Denmark, France, Germany, India, Israel, Italy, Japan, Netherlands, the Russian Federation, Singapore, South Africa, South Korea, Sweden, Switzerland, and the United Kingdom. We expect about 400 attendees in 2013.
A conference near the United States Patent and Trademark Office (USPTO) in Alexandria, Virginia, USA.
For more information please visit PIUG website.
Hilton Alexandria Mark Center
5000 Seminary Road, Alexandria, VA
Virginia, United States, 22311
Back
The process of invention is complete only with the IP protection provided in law. That's where MBM comes in. We match our clients' creative thinking with the creative protection needed to achieve their goals.
Health Canada recently announced that section 2.1 of its Guidance Document re: Data Protection has been amended to clarify that the prior approval of a medicinal ingredient in a drug for veterinary use will not preclude the granting of data protection for a drug for...